COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,519 Articles (22,380 medRxiv, 8,139 bioRxiv)

Most recent first Previous |  Page 255: Articles 2541-2550  | Next

Impact of sampling site on diagnostic test accuracy of RT-PCR in diagnosing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection since the emergence of omicron: a systematic review and meta-analysis
Saal-Bauernschubert, L., Wagner, C., Fomenko, A., Daehne, T., Bora, A.-M., Janka, H., Stangl, S., Skoetz, N., Weibel, S.
10.1101/2023.10.09.23296728 — Posted: 2023-10-09
Covid-19 vaccine safety in pregnancy, a nested case-control study in births from April 2021 to March 2022, England
Mensah, A. A., Stowe, J., Jardine, J. E., Kirsebom, F. C., Clare, T., Kall, M., Campbell, H., Lopez-Bernal, J., Andrews, N.
10.1101/2023.10.09.23296737 — Posted: 2023-10-09
Unravelling Causal Associations between Population Mobility and COVID-19 Cases in Spain: a Transfer Entropy Analysis
Ponce de Leon, M., Pontes, C., Arenas, A., Valencia, A.
10.1101/2023.10.09.23296732 — Posted: 2023-10-09
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection
Martins, M., Nooruzzaman, M., Cunningham, J. L., Ye, C., Caserta, L. C., Jackson, N., Martinez-Sobrido, L., Fang, Y., Diel, D. G.
10.1101/2023.10.09.561473 — Posted: 2023-10-09
LETHAL COVID-19 ASSOCIATES WITH RAAS-INDUCED INFLAMMATION FOR MULTIPLE ORGAN DAMAGE INCLUDING MEDIASTINAL LYMPH NODES
Guarnieri, J. W., Topper, M., Beigel, K., Haltoom, J. A., Chadburn, A., Frere, J., An, J., Cope, H., Borczuk, A., Sinha, S., Lim, C., Kim, J., Park, J., Meydan, C., Foox, J., Mozsary, C., Bram, Y., Richard, S., Epsi, N., Agan, B., Chenoweth, J., Simons, M., Tribble, D., Burgess, T., Dalgard, C. L., Heise, M. T., Moorman, N., Baxter, V., Madden, E. A., Taft-Benz, S., Anderson, E., Sanders, W. A., Dickmander, R. J., Widjaja, G. A., Janssen, K., Lie, T., Murdock, D. G., Angelin, A., Albrecht, Y. E. S., Olali, A., Dybas, J. M., Priebe, W., Emmett, M. R., Best, S., Johnson, M. K., Trovao, N. S., Clark, K. B., Zaksiene, V., Miller, R., Grabhamr, P., Schisler, J. C., Moraes-vieira, P., Pollett, S., Mason, C. E., Wurtele, E. S., Taylor, D., Schwartz, R. E., Beheshti, A., Wallace, D. C., Baylin, S. B.
10.1101/2023.10.08.561395 — Posted: 2023-10-09
Direct measures of liking and intensity of taste, smell, and chemesthetic stimuli are similar between young people reporting they did or did not have COVID-19
Leszkowicz, E., Bell, K., Huang, A., Nguyen, H., Reed, D. R.
10.1101/2023.10.07.561170 — Posted: 2023-10-09
Sequence-based Protein-Protein Interaction Prediction Using Multi-kernel Deep Convolutional Neural Networks with ProteinLanguage Model
Vu, A.
10.1101/2023.10.03.560728 — Posted: 2023-10-09
The macroeconomic and epidemiological impacts of Covid-19 in Pakistan.
Jensen, H. T., Keogh-Brown, M. R., Eggo, R. M., Pearson, C. A. B., Torres-Rueda, S., Huda, M., Khalid, M., Sulfiqar, W., CMMID COVID-19 Working Group, , Smith, R. D., Jit, M., Vassall, A.
10.1101/2023.10.06.23296657 — Posted: 2023-10-06
Understanding SARS-CoV-2 Spike glycoprotein clusters and their impact on immunity of the population from Rio Grande do Norte, Brazil
Teixeira, D. G., Rodrigues-Neto, J. F., Severiano da Cunha, D. C., Jeronimo, S. M.
10.1101/2023.10.05.561101 — Posted: 2023-10-06
Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective againstOmicron
Bottero, D., Rudi, E., Aispuro, P. M., Zurita, M. E., Gaillard, M. E., Ledesma, M. M. G. L., Malito, J., Stuible, M., Ambrosis, N. M., Durocher, Y., Gamarnik, A., Wigdorovitz, A., Hozbor, D.
10.1101/2023.10.05.557343 — Posted: 2023-10-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).